NasdaqGS:UTHRBiotechs
Did a High-Profile Board Addition and ESOP Moves Just Shift United Therapeutics' (UTHR) Investment Narrative?
United Therapeutics Corporation recently expanded its Board of Directors to 13 members and appointed Victor Dzau, M.D., a globally recognized physician-scientist and former President of the National Academy of Medicine, as a director without initial committee assignments.
Alongside this high-profile governance addition, the company has been active with employee stock ownership plan-related shelf registrations, highlighting ongoing efforts to align long-term employee incentives with its...